Asset Management One’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-106,324
| Closed | -$19.5M | – | 1078 |
|
|
2021
Q2 | $19.5M | Sell |
106,324
-1,185
| -1% | -$203K | 0.07% | 280 |
|
|
2021
Q1 | $16.4M | Sell |
107,509
-1,541
| -1% | -$238K | 0.07% | 324 |
|
|
2020
Q4 | $16.9M | Sell |
109,050
-1,070
| -1% | -$137K | 0.07% | 298 |
|
|
2020
Q3 | $12.6M | Sell |
110,120
-5,153
| -4% | -$556K | 0.06% | 330 |
|
|
2020
Q2 | $12.9M | Sell |
115,273
-1,582
| -1% | -$168K | 0.06% | 310 |
|
|
2020
Q1 | $10.5M | Sell |
116,855
-7,386
| -6% | -$725K | 0.06% | 310 |
|
|
2019
Q4 | $13.4M | Buy |
124,241
+970
| +0.8% | +$104K | 0.06% | 337 |
|
|
2019
Q3 | $12.1M | Sell |
123,271
-4,491
| -4% | -$506K | 0.06% | 348 |
|
|
2019
Q2 | $16.7M | Buy |
127,762
+10,654
| +9% | +$1.37M | 0.08% | 264 |
|
|
2019
Q1 | $15.8M | Sell |
117,108
-249,638
| -68% | -$31M | 0.09% | 256 |
|
|
2018
Q4 | $35.7M | Buy |
366,746
+1,983
| +0.5% | +$234K | 0.09% | 258 |
|
|
2018
Q3 | $50.7M | Buy |
364,763
+8,424
| +2% | +$1.06M | 0.1% | 212 |
|
|
2018
Q2 | $44.2M | Buy |
356,339
+2,737
| +0.8% | +$320K | 0.1% | 227 |
|
|
2018
Q1 | $39.4M | Buy |
353,602
+2,278
| +0.6% | +$272K | 0.09% | 248 |
|
|
2017
Q4 | $42M | Sell |
351,324
-1,881
| -0.5% | -$229K | 0.09% | 239 |
|
|
2017
Q3 | $49.5M | Buy |
353,205
+7,232
| +2% | +$983K | 0.12% | 196 |
|
|
2017
Q2 | $42.1M | Sell |
345,973
-5,247
| -1% | -$611K | 0.11% | 214 |
|
|
2017
Q1 | $42.6M | Sell |
351,220
-31,716
| -8% | -$4.09M | 0.11% | 209 |
|
|
2016
Q4 | $46.9M | Buy |
382,936
+283,411
| +285% | +$34.7M | 0.12% | 192 |
|
|
2016
Q3 | $12M | Sell |
99,525
-17,722
| -15% | -$2.28M | 0.18% | 132 |
|
|
2016
Q2 | $13.4M | Buy |
117,247
+12,844
| +12% | +$1.82M | 0.2% | 116 |
|
|
2016
Q1 | $14.1M | Buy |
104,403
+10,760
| +11% | +$1.58M | 0.21% | 112 |
|
|
2015
Q4 | $18M | Buy |
93,643
+2,123
| +2% | +$371K | 0.27% | 78 |
|
|
2015
Q3 | $13.6M | Sell |
91,520
-20,854
| -19% | -$3.8M | 0.21% | 111 |
|
|
2015
Q2 | $20M | Sell |
112,374
-506
| -0.4% | -$87.3K | 0.28% | 72 |
|
|
2015
Q1 | $20.3M | Buy |
112,880
+28,685
| +34% | +$5.19M | 0.25% | 84 |
|
|
2014
Q4 | $15.9M | Buy |
84,195
+6,767
| +9% | +$1.25M | 0.21% | 115 |
|
|
2014
Q3 | $13M | Buy |
77,428
+50,176
| +184% | +$8.24M | 0.18% | 130 |
|
|
2014
Q2 | $4.29M | Sell |
27,252
-6,342
| -19% | -$1M | 0.06% | 338 |
|
|
2014
Q1 | $5.04M | Sell |
33,594
-17,029
| -34% | -$2.71M | 0.08% | 273 |
|
|
2013
Q4 | $6.67M | Sell |
50,623
-3,932
| -7% | -$472K | 0.1% | 231 |
|
|
2013
Q3 | $6.35M | Sell |
54,555
-516
| -0.9% | -$56.6K | 0.1% | 229 |
|
|
2013
Q2 | $5.16M | Buy |
+55,071
| New | +$5.31M | 0.08% | 249 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM